FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P. Angus, Gary L. Johnson, Gaurav Mehta et al.|npj Breast Cancer|2021Cited by 24
Impact of supraphysiologic MDM2 expression on chromatin networks and therapeutic responses in sarcomaSamantha M. Bevill, B Bernstein|Cell Genomics|2023Cited by 12